Prevalence of anti-tuberculosis drug resistance in foreign-born tuberculosis cases in the u.s. and in their countries of origin

HIGHLIGHTS

• who: Allison B. Taylor and colleagues from the Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, the USCenters for Disease Control and Prevention, AtlantaEditor: Madhukar Pai, McGill University, Canada have published the Article: Prevalence of Anti-Tuberculosis Drug Resistance in Foreign-Born Tuberculosis Cases in the U.S. and in Their Countries of Origin, in the Journal: PLOS ONE | www.plosone.org of June/25,/2012
• what: The authors focused the analysis on prevalence of isoniazid resistance because LTBI is usually treated with isoniazid alone, and on multidrug . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.